Target intelligence / Profile preview

B-cell antigen receptor (BCR) specific for SARS-CoV-2 receptor-binding domain (RBD) epitopes (SARS-CoV-2 RBD-specific BCR)

Target
SARS-CoV-2 RBD-specific BCR
Molecular classification
Receptor, Immunoglobulin, Glycoprotein
01

Overview

The B-cell antigen receptor (BCR) specific for the SARS-CoV-2 receptor-binding domain (RBD) is a membrane-bound immunoglobulin complex that plays a pivotal role in the adaptive immune response to COVID-19. Located on the surface of B lymphocytes, these receptors specifically recognize and bind to epitopes within the RBD of the viral spike protein, which is the primary mediator of viral entry into host cells via the ACE2 receptor (Robbiani et al., Nature 2020). Upon antigen binding, the BCR initiates a signaling cascade that leads to B-cell activation, germinal center formation, and the production of high-affinity neutralizing antibodies (Turner et al., Nature 2021). This target is the primary focus of most COVID-19 vaccines, which aim to elicit a robust population of RBD-specific memory B cells to provide long-lasting protection (Sakharkar et al., Nature Communications 2021). The diversity and affinity of these receptors determine the breadth of the immune response against various SARS-CoV-2 variants (Gaebler et al., Nature 2021). Monitoring the frequency and evolution of RBD-specific BCRs serves as a critical biomarker for assessing the durability of vaccine-induced immunity. Understanding the structural basis of BCR-RBD interactions is also vital for the development of next-generation vaccines and therapeutic monoclonal antibodies. These receptors are essential for the generation of immunological memory, allowing the host to respond more rapidly and effectively upon re-exposure to the virus.

Other names
SARS-CoV-2 RBD-specific B-cell receptorAnti-SARS-CoV-2 RBD BCRSpike RBD-specific BCRAnti-RBD B-cell antigen receptor
02

Mechanism of action

Vaccine-delivered antigens (e.g., mRNA-encoded spike protein or recombinant RBD) bind to the BCR on naive or memory B cells, inducing receptor clustering and intracellular signaling through the Ig-alpha/Ig-beta (CD79a/CD79b) complex, which leads to B-cell proliferation and differentiation (Turner et al., Nature 2021).

03

Biological functions

Immune responseAntigen recognitionB-cell activationSignal transductionClonal expansion
04

Disease associations

Infection
05

Safety considerations

Original antigenic sin (immune imprinting) (Reynolds et al., Science 2022)Antibody-dependent enhancement (ADE) (Arvin et al., Nature 2020)Reduced efficacy against emerging variants (Gaebler et al., Nature 2021)
06

Interacting drugs

BNT162b2 (Comirnaty)

4 more in the full profile.

07

Biomarkers

RBD-specific memory B cell frequency (Gaebler et al., Nature 2021)Serum anti-RBD IgG titers (Robbiani et al., Nature 2020)Neutralizing antibody levels (Turner et al., Nature 2021)Somatic hypermutation rates in BCR sequences (Sakharkar et al., Nature Communications 2021)

Beyond the preview

Go deeper on B-cell antigen receptor (BCR) specific for SARS-CoV-2 receptor-binding domain (RBD) epitopes (SARS-CoV-2 RBD-specific BCR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on B-cell antigen receptor (BCR) specific for SARS-CoV-2 receptor-binding domain (RBD) epitopes (SARS-CoV-2 RBD-specific BCR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call